Live Breaking News & Updates on Novabay Pharmaceuticals Trading Down|Page 2

Stay updated with breaking news from Novabay pharmaceuticals trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

LUXO Reaches Self Reported Market Cap of $103.50 Million (LUXO)

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) released its earnings results on Thursday. The biopharmaceutical company reported ($0.85) earnings per share (EPS) for the quarter, reports. NovaBay Pharmaceuticals had a negative return on equity of 18.62% and a negative net margin of 21.09%. The business had revenue of $3.12 million for the quarter. NovaBay Pharmaceuticals Trading […] ....

News Ratings For Novabay Pharmaceuticals Daily , Renaissance Technologies , Institutional Investors Weigh In On Novabay Pharmaceuticals , Earnings History For Novabay Pharmaceuticals , Novabay Pharmaceuticals Trading Down , Virtu Financial , Novabay Pharmaceuticals Inc , Novabay Pharmaceuticals , Armistice Capital , Get Rating , Bay Pharmaceuticals , Bay Pharmaceuticals Trading Down , Capital Management , Novabay Pharmaceuticals Daily ,

NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by StockNews.com

Analysts at StockNews.com began coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Rating) in a research note issued on Monday. The brokerage set a “hold” rating on the stock. NovaBay Pharmaceuticals Trading Down 1.7 % Shares of NYSE:NBY opened at $1.70 on Monday. The business’s 50 day moving average is $2.01 and its 200-day […] ....

Novabay Pharmaceuticals , Novabay Pharmaceuticals Inc , Novabay Pharmaceuticals Trading Down , Novabay Pharmaceuticals Company Profile , News Ratings For Novabay Pharmaceuticals Daily , Get Rating , Bay Pharmaceuticals Trading Down , Bay Pharmaceuticals , Ramin Najafi , Novabay Pharmaceuticals Daily , Nyse Nby , Initiated Coverage , Stocknews Com ,